Literature DB >> 2793164

Impairment of capping in lymphoblastoid cell lines of Duchenne patients indicates an intrinsic cellular defect.

O R Baricordi1, A Sensi, A Balboni, G Romeo, M Rocchi, L Melchiorri, E Gandini.   

Abstract

Duchenne muscular dystrophy (DMD) is a lethal sex-linked degenerative disorder of the muscle in man. Generalized cell membrane abnormalities seem to be involved in the pathogenesis of the disease; in particular, the impairment of lymphocyte capping capacities has been repeatedly confirmed. To clarify whether capping impairment is a consequence of factors related to the activity of the disease or an expression of an intrinsic cellular defect, we have investigated the capping capacities of DMD EBV-transformed cell lines. The results indicate a significant impairment of capping capacity in cultured cell lines, providing evidence for an intrinsic cell deficiency in DMD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793164     DOI: 10.1007/bf00285158

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

1.  Subcellular fractionation of dystrophin to the triads of skeletal muscle.

Authors:  E P Hoffman; C M Knudson; K P Campbell; L M Kunkel
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

2.  Duchenne muscular dystrophy gene product is not identical in muscle and brain.

Authors:  U Nudel; D Zuk; P Einat; E Zeelon; Z Levy; S Neuman; D Yaffe
Journal:  Nature       Date:  1989-01-05       Impact factor: 49.962

3.  Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

4.  Impaired HLA capping capacity of peripheral blood lymphocytes in Duchenne muscular dystrophy.

Authors:  A Sensi; A Venturoli; S Traniello; M Lucci; C Vullo; C Conighi; P L Mattiuz; O R Båricordi
Journal:  J Med Genet       Date:  1984-06       Impact factor: 6.318

5.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

6.  Clonal transformation of adult human leukocytes by Epstein-Barr virus.

Authors:  B Sugden; W Mark
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

7.  The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle.

Authors:  E E Zubrzycka-Gaarn; D E Bulman; G Karpati; A H Burghes; B Belfall; H J Klamut; J Talbot; R S Hodges; P N Ray; R G Worton
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

8.  Systemic membrane defect and the inhibition of lymphocyte capping in Duchenne muscular dystrophy.

Authors:  B M Goldsmith; H D Gruemer
Journal:  Clin Chim Acta       Date:  1987-04-15       Impact factor: 3.786

9.  Transcription of the dystrophin gene in human muscle and non-muscle tissue.

Authors:  J Chelly; J C Kaplan; P Maire; S Gautron; A Kahn
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

10.  Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment.

Authors:  A P Monaco; C J Bertelson; W Middlesworth; C A Colletti; J Aldridge; K H Fischbeck; R Bartlett; M A Pericak-Vance; A D Roses; L M Kunkel
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.